Compare · LEVI vs PASW
LEVI vs PASW
Side-by-side comparison of Levi Strauss & Co (LEVI) and Ping An Biomedical Co. Ltd. (PASW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LEVI and PASW operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- LEVI is the larger of the two at $7.92B, about 475.5x PASW ($16.7M).
- LEVI has hit the wire 8 times in the past 4 weeks while PASW has been quiet.
- LEVI has more recent analyst coverage (25 ratings vs 0 for PASW).
- Company
- Levi Strauss & Co
- Ping An Biomedical Co. Ltd.
- Price
- $20.42-1.14%
- $0.12-2.66%
- Market cap
- $7.92B
- $16.7M
- 1M return
- +2.82%
- -
- 1Y return
- -2.13%
- -
- Industry
- Apparel
- Apparel
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 1999
- News (4w)
- 8
- 0
- Recent ratings
- 25
- 0
Levi Strauss & Co
Levi Strauss & Co. operates as an apparel company. It designs, markets, and sells jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear, and related accessories for men, women, and children in the Americas, Europe, and Asia. The company sells its products under the Levi's, Dockers, Signature by Levi Strauss & Co., and Denizen brands; and also licenses its Levi's and Dockers trademarks for various product categories, including footwear, belts, wallets and bags, outerwear, sweaters, dress shirts, kids wear, sleepwear, and hosiery. The company sells its products through third-party retailers, such as department stores, specialty retailers, third-party e-commerce sites, and franchisees who operate brand-dedicated stores; and directly to consumers through various formats, including company-operated mainline and outlet stores, company-operated e-commerce sites, and select shop-in-shops located in department stores and other third-party retail locations. It operates approximately 3,100 brand-dedicated stores and shop-in-shops. The company was founded in 1853 and is headquartered in San Francisco, California.
Latest LEVI
- Amendment: SEC Form SCHEDULE 13G/A filed by Levi Strauss & Co
- SEC Form 8-K filed by Levi Strauss & Co
- SEC Form 10-Q filed by Levi Strauss & Co
- Levi Strauss & Co. Reports Third-Quarter Results
- SEC Form 4 filed by Levi Strauss & Co
- Levi Strauss & Co filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Levi Strauss & Co. Appoints John Vandemore as Chief Financial Officer
- Levi Strauss & Co. to Webcast Third Quarter 2026 Earnings Conference Call
- Levi Strauss & Co filed SEC Form 8-K: Leadership Update
- Director Prime Joshua E was granted 106 shares, increasing direct ownership by 0.14% to 73,422 units (SEC Form 4)
Latest PASW
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 3 filed by new insider Liu Pijun (Pjl)
- SEC Form 3 filed by new insider Liu Xianzhi (Xzl)
- SEC Form 3 filed by new insider Yang Hongli (Hly)
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital